Investigative Ophthalmology & Visual Science, Vol 38, 2144-2151, Copyright © 1997 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Endothelin expression in ocular tissues of diabetic and insulin-treated rats

U Chakravarthy, RG Hayes, AW Stitt and A Douglas
Department of Ophthalmology, Queen's University of Belfast, Northern Ireland, UK.

PURPOSE: The endothelins are potent vasoactive peptides that are widely distributed in ocular tissues. There is evidence linking the endothelins to vascular dysfunction in diabetic microangiopathy. Thus, the synthesis and distribution of endothelin-1 (ET-1) and endothelin-3 (ET-3) were studied in the retinas of diabetic and nondiabetic animals. METHODS: Levels of ET-1 and ET-3 were determined by radioimmunoassay in ocular tissues of normal rats, and in rats with streptozotocin-induced diabetes of 6 and 12 weeks' duration, insulin-treated and untreated. In a separate cohort of similarly treated animals, retinal vascular trypsin digest preparations were immunostained, using antibodies raised against ET-1 and ET-3. RESULTS: Ocular ET-1 levels were elevated twofold in diabetic animals that received insulin treatment for 7 days when compared with levels in normal rats. Insulin treatment for 10 days before death caused a fourfold elevation of ET-1 in ocular tissues. Endothelin-1 was also increased in 12-week-old diabetic animals and in those maintained on insulin throughout their period of diabetes. Immunofluorescence to anti-ET-1 within the capillary bed and veins of the retina in diabetic insulin-treated animals was elevated when compared with digests from normal litter-matched control animals. Ocular tissue ET-3 levels were unaffected by diabetes. CONCLUSIONS: Overall ocular and retinal tissue levels of ET-1 were selectively elevated by diabetes and insulin treatment, suggesting that the endothelins may be involved in the pathogenesis of diabetic retinal microangiopathy.

This article has been cited by other articles:

				R. Roberts, H. Luan, and B. A. Berkowitz Blocking ET-1 Receptors Does Not Correct Subnormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3550 - 3555. [Abstract] [Full Text] [PDF]

				K. Masuzawa, S. Jesmin, S. Maeda, S. Zaedi, N. Shimojo, T. Miyauchi, and K. Goto Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Experimental Biology and Medicine, June 1, 2006; 231(6): 1090 - 1094. [Abstract] [Full Text] [PDF]

				K. Matsushita and D. G. Puro Topographical heterogeneity of KIR currents in pericyte-containing microvessels of the rat retina: effect of diabetes J. Physiol., June 1, 2006; 573(2): 483 - 495. [Abstract] [Full Text] [PDF]

				H. Kawamura, H. Oku, Q. Li, K. Sakagami, and D. G. Puro Endothelin-Induced Changes in the Physiology of Retinal Pericytes Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 882 - 888. [Abstract] [Full Text] [PDF]

				M. Tadesse, Y. Yan, P. Yossuck, and R. D. Higgins Captopril Improves Retinal Neovascularization via Endothelin-1 Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1867 - 1872. [Abstract] [Full Text] [PDF]

				A. Iannaccone, C. Letizia, S. Pazzaglia, E. M Vingolo, G. Clemente, and M. R Pannarale Plasma endothelin-1 concentrations in patients with retinal vein occlusions Br. J. Ophthalmol., May 1, 1998; 82(5): 498 - 503. [Abstract] [Full Text]